Blueshift Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Blueshift Asset Management's PFE Position: Q2 2026 in Review
Blueshift Asset Management opened a new position in Pfizer (PFE) in Q2 2026: 40,820 shares worth $983K. The stake represents 0.23% of the portfolio and ranks #72 among its holdings. This is a return to the name: Blueshift Asset Management previously reported a position in PFE as recently as Q4 2025.
Blueshift Asset Management first reported a position in PFE in Q4 2018 and has held it in 16 quarters since. The position peaked at $7.09M in Q4 2020. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Blueshift Asset Management held 40,820 shares of Pfizer worth $983K as of Q2 2026.
- Pfizer was a new Blueshift Asset Management position in Q2 2026.
- Pfizer made up 0.23% of Blueshift Asset Management's portfolio in Q2 2026, its #72 holding.
- Blueshift Asset Management first reported a position in Pfizer in Q4 2018 and has held it in 16 quarters since.
- Blueshift Asset Management's Pfizer position peaked at $7.09M in Q4 2020.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.